Electroporation for Cancer Treatment Real World Registry (PIONEER)

Mirai Medical

Status: Enrolling

Conditions: Gastrointestinal Cancer; Skin Cancer

Study type: Observational

Funder types: Industry

Identifiers

NCT04929912

CIP-21-001

Details and patient eligibility

About

This registry aims to assess real-world long-term disease outcomes for patients treated using reversible electroporation and a chemotherapeutic or calcium; in particular tumour response rates and recurrence rates. The study also aims to characterise side effects and the occurrence of Adverse Events and their relationship to the treatment.

Enrollment: 1,000 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Any patient who has been treated using Calcium Electroporation
• Any patient who has been treated using Electrochemotherapy
• Patients must be mentally capable of understanding the information given
• Patients must give written informed consent.

Exclusion criteria

• None

Trial design